Middle East Pharmaceutical Industries Company (TADAWUL:4016)

Saudi Arabia · Delayed Price · Currency is SAR

66.85

+0.15 (0.22%)

Sep 3, 2026, 3:10 PM AST

Market Cap	2.34B -7.9%
Revenue (ttm)	512.08M +18.5%
Net Income	108.50M +16.8%
EPS	3.10 +16.8%
Shares Out	35.00M
PE Ratio	21.56
Forward PE	n/a
Dividend	1.38 (2.06%)
Ex-Dividend Date	Sep 2, 2026

Volume	51,079
Open	66.65
Previous Close	66.70
Day's Range	66.65 - 67.40
52-Week Range	53.89 - 79.09
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 5, 2026

About TADAWUL:4016

Middle East Pharmaceutical Industries Company (MEPIC), established in Riyadh, Saudi Arabia, in 1998, is a global pharmaceutical entity. The company's core activities encompass the entire lifecycle of generic medicines and various pharmaceutical products, from research and development to manufacturing and sales, catering to both local and international markets. Its business operations are strategically divided into private sector, public sector, and export divisions. MEPIC offers an extensive array of products designed to address a wide range of... [Read more]

Industry Medical - Pharmaceuticals

Sector Healthcare

Founded 1998

Employees 731

Stock Exchange Saudi Stock Exchange

Ticker Symbol 4016

Full Company Profile

Financial Performance

In 2025, TADAWUL:4016's revenue was 460.48 million, an increase of 16.87% compared to the previous year's 394.00 million. Earnings were 97.01 million, an increase of 21.49%.

Financial Statements